Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Key Points
The transaction represented 3% of the insider's direct equity holdings before the filing.
The sale was conducted directly through an open-market transaction under a pre-established Rule 10b5-1 trading plan.
The activity represents routine portfolio management as part of an amended filing to correct previously omitted transaction volume.
- 10 stocks we like better than Omada Health ›
Wei-Li Shao, President of Omada Health (NASDAQ:OMDA), sold 9,418 shares of the company on Aug. 12, 2026, according to a recent SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $236,000 |
| Shares sold | 9,418 |
| Post-transaction shares (directly held) | 307,372 |
| Post-transaction value | $7.3 million |
Transaction value based on SEC Form 4 weighted average sale price ($25.02); post-transaction value based on Aug. 12, 2026, market close ($23.84).
Key questions
- What governed the timing of this executive sale?
The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the president on March 13, 2026. These plans allow insiders to establish a pre-determined schedule for selling stock to avoid concerns regarding material non-public information. - How does this disposal affect the insider's total equity exposure?
The president continues to hold over 307,000 shares directly after the transaction. As of the Sept. 4, 2026, market close, this remaining direct position was valued at approximately $7 million based on a stock price of $22.77. - What was the performance context of the stock at the time of the sale?
As of the Aug. 12, 2026, transaction date, Omada Health shares had appreciated by 24% over the preceding 12-month period. - What is the company's current scale of operations and financial standing?
Omada Health provides virtual care programs, including cardiometabolic support for prediabetes and hypertension. The company reported trailing-twelve-month revenue of $309.8 million and net income of $4.3 million, supported by a staff of 946 employees.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-09-04) | $22.77 |
| Market Capitalization | $1.3 billion |
| Revenue (TTM) | $309.80 million |
| Net Income (TTM) | $4.30 million |
Company Snapshot
- Omada Health delivers comprehensive virtual care programs focused on cardiometabolic conditions, including prediabetes, diabetes, and hypertension, as well as physical therapy services for musculoskeletal conditions and behavioral health support programs.
- The company generates revenue through employer-sponsored and payer-based virtual care delivery models, providing digital health solutions that address chronic disease management and preventive care across its platform.
- Omada's primary customers include health plans, employers, and healthcare systems seeking to reduce healthcare costs and improve clinical outcomes for members with chronic conditions.
Omada Health operates as a leading digital health platform with approximately 946 employees and a market capitalization of $1.3 billion. The company has demonstrated strong growth momentum, with TTM revenue of $309.80 million and a 35.4% stock price appreciation thus far in 2026, reflecting investor confidence in its virtual care delivery model. Omada's competitive positioning is anchored in its integrated suite of evidence-based programs and proprietary technology platform designed to engage patients and drive measurable health outcomes across multiple chronic disease categories.
What this transaction means for investors
On Aug. 12, Shao sold over 9,400 shares in a transaction valued at approximately $236,000. Looking into the details, this transaction appears to be just a routine sale. The main reason is that this sale was already part of a trading plan established in March 2026. That means the sale can't be interrupted as a signal that the insider may have been worried about the state of the company and decided to sell shares in a spur-of-the-moment decision. Also, supporting the appearance of a routine sale is the number of shares Shao still retains. Although the insider sold 9,418 shares, Shao still directly holds 307,372 shares. That indicates continued alignment with the company's current and future success. Finally, given how well the stock has performed thus far in 2026, it should help to put investors' minds at ease.
The stock has faced a bit of a pullback over the last month, with shares sliding 11.2% as of this writing. That said, the stock price is still meaningfully up in 2026, climbing 35.4%. In comparison, the S&P 500 is up 13.4% over the same period. That's why, with all that context, this doesn't appear to be a transaction, in and of itself, that shareholders should worry about.
Should you buy stock in Omada Health right now?
Before you buy stock in Omada Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Omada Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $395,625!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,397,147!*
Now, it’s worth noting Stock Advisor’s total average return is 951% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of September 23, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Omada Health. The Motley Fool has a disclosure policy.
Recommended Articles
